FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Noven Pharmaceuticals Daytrana Recall

Daytrana (methylphenidate transdermal system) Transdermal Patch, 20 mg over 9 hours (2

Noven Pharmaceuticals, Inc. · Miami, FL

Risk level
Class II
Reported by FDA
Jul 20, 2016
Recall ID
D-1439-2016
Check your lot numberHow we source this data

Summary

Noven Pharmaceuticals recalled Daytrana starting Dec 21, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1439-2016 on Jul 20, 2016. Reason: Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration. Status: Terminated.

Why it was recalled

Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.

Product description

Daytrana (methylphenidate transdermal system) Transdermal Patch, 20 mg over 9 hours (2.2 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5554-3.

Lot numbers, UPCs & expiration codes

Lot # 77140, Exp 05/16

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1439-2016
Classification
Class II
Status
Terminated
Recall initiated
Dec 21, 2015
FDA report date
Jul 20, 2016
Quantity
2088 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Noven Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1439-2016, exactly as published.

Show all FDA fields
City
Miami
State
FL
Status
Terminated
Country
United States
Event ID
73718
Address
11960 SW 144th St
Code information
Lot # 77140, Exp 05/16
Postal code
33186-6109
Report date
Jul 20, 2016
Product type
Drugs
Recall number
D-1439-2016
Classification
Class II
Recalling firm
Noven Pharmaceuticals, Inc.
Product quantity
2088 boxes
Termination date
Mar 19, 2019
Reason for recall
Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Daytrana (methylphenidate transdermal system) Transdermal Patch, 20 mg over 9 hours (2.2 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5554-3.
Distribution pattern
Nationwide
Recall initiation date
Dec 21, 2015
Initial firm notification
Letter
Center classification date
Jul 14, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1439-2016, published Jul 20, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls